775351-54-7

Basic information

• Product Name: 2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzonitrile
• Synonyms: 2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzonitrile ;4-Cyano-3-methylphenylboronic acid pinacol ester
• CAS NO: 775351-54-7
• Molecular Formula: C₁₄H₁₈BNO₂
• Molecular Weight: 243.12
• Mol File: 775351-54-7.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 368.7±35.0 °C(Predicted)
• Appearance: /
• Density: 1.05±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzonitrile(775351-54-7)
• EPA Substance Registry System: 2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzonitrile(775351-54-7)

Safety Data

• Hazardous Substances Data: 775351-54-7(Hazardous Substances Data)

Upstream product

• 67832-11-5 4-bromo-2-methylbenzonitrile 
• 73183-34-3 bis(pinacol)diborane 
• 61676-62-8 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 

Downstream Products

• 1308668-18-9 (S)-4-(4-(1-hydroxyethyl)pyridin-3-yl)-2-methylbenzonitrile 
• 1308668-16-7 (R)-4-(4-(1-hydroxyethyl)pyridin-3-yl)-2-methylbenzonitrile 
• 1308668-14-5 4-(4-(1-hydroxyethyl)pyridin-3-yl)-2-methylbenzonitrile 
• 1308669-68-2 4-(4-formylpyridin-3-yl)-2-methylbenzonitrile 

Relevant articles and documents

KINASE ANTAGONISTS AND METHODS FOR MAKING AND USING THEM

Disclosed herein are small molecule compounds that are SGK1 antagonists, formulations and pharmaceutical compositions comprising the compounds, and methods of making and using them, for treating, ameliorating, preventing, reversing or slowing the progression of: a cancer, a tumor, a metastasis or a dysplastic or a dysfunctional cell condition responsive to inhibition of a kinase enzyme of the AGC group of kinases including SGK1, by administration of an AGC kinase inhibitor or antagonist.

6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE DERIVATIVES AND THEIR USE AS PHD INHIBITORS

The present invention provides compounds of formula (I) which are useful as inhibitors of PHD, pharmaceutical compositions thereof, methods for treatment of conditions associated with HIF, processes for making the compounds and intermediates thereof.

4, 5-DIHYDRO-LH-PYRAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL USES

Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.